Inactivation of the anticancer drugs doxorubicin and oracin by aldo–keto reductase (AKR) 1C3
Authors:
- Vladimir WsolVWVladimir Wsol
- Guangming XiongGXGuangming Xiong
- Edmund MaserEMEdmund Maser
- 10 September 2008
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 181 (1) , 1-6